Works matching IS 02780232 AND DT 2023 AND VI 41 AND IP 2

Results: 9

Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 230, doi. 10.1002/hon.2993

By:

Li, Xiao;
Liu, Mengke;
Shi, Qing;
Fang, Ying;
Fu, Di;
Shen, Zhi‐xiang;
Yi, Hongmei;
Wang, Li;
Zhao, Weili

Publication type:

Article

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti‐CD19‐chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B‐cell lymphoma and high tumor burden

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 275, doi. 10.1002/hon.2981

By:

Mu, Juan;
Deng, Haobin;
Lyu, Cuicui;
Yuan, Jijun;
Li, Qing;
Wang, Jia;
Jiang, Yanyu;
Deng, Qi;
Shen, Jichun

Publication type:

Article

TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 285, doi. 10.1002/hon.2962

By:

Zhou, Bai;
Tang, Chao;
Chen, Guiyang;
Jiang, Tiebin;
Shi, Xiao;
Wang, Fen

Publication type:

Article

Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 257, doi. 10.1002/hon.2954

By:

Song, Wenting;
Chen, Zhan;
Shi, Cunzhen;
Gao, Yuyang;
Feng, Xiaoyan;
Li, Hongwen;
Li, Zhaoming;
Zhang, Mingzhi

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2023, v. 41, n. 2, p. 219, doi. 10.1002/hon.3019
Publication type:: Article

Primary treatment and recent survival trends in patients with primary diffuse large B‐cell lymphoma of central nervous system, 1995–2016: A population‐based SEER analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 248, doi. 10.1002/hon.2918

By:

Chen, Cui;
Sun, Peng;
Sun, Xiao‐Qing;
Chen, Shao‐Yong;
Hang Yang;
Wang, Yu;
Li, Zhi‐Ming

Publication type:

Article

Review on natural killer/T‐cell lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 221, doi. 10.1002/hon.2944

By:

He, Xiaohua;
Gao, Yan;
Li, Zhiming;
Huang, Huiqiang

Publication type:

Article

Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 239, doi. 10.1002/hon.2928

By:

Lang, Mingxiao;
Feng, Youqin;
Meng, Xiangrui;
Zhao, Jing;
Song, Zheng;
Qian, Zhengzi;
Qiu, Lihua;
Zhou, Shiyong;
Liu, Xianming;
Li, Lanfang;
Yang, Haiyan;
Song, Yuqin;
Li, Wei;
Zhang, Huilai

Publication type:

Article

Clinical analysis of patients with primary and secondary extranodal natural killer/T‐cell lymphoma of central nervous system.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 267, doi. 10.1002/hon.2894

By:

Li, Xingying;
Yu, Hui;
Fu, Xiaorui;
Zhang, Lei;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Sun, Zhenchang;
Zhang, Xudong;
Li, Zhaoming;
Wu, Jingjing;
Chang, Yu;
Yan, Jiaqin;
Zhou, Zhiyuan;
Nan, Feifei;
Wu, Xiaolong;
Tian, Li;
Zhang, Mingzhi

Publication type:

Article